Skip to content

cArdiac Non Invasive MApping in resynchronizaTION

cArdiac Non Invasive MApping in resynchronizaTION Registry

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04347109
Acronym
ANIMATION
Enrollment
50
Registered
2020-04-15
Start date
2019-09-01
Completion date
2025-12-31
Last updated
2024-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Resynchronization Therapy

Keywords

non invasive mapping, cardiac resynchronization therapy, pacing-induced cardiomyopathy, electrical shock

Brief summary

Non-invasive mapping using the Cardio Insight system is performed in heart failure patients requiring biventricular pacing to optimize therapy, and understand mechanisms underlying pacing-induced cardiomyopathy and ventricular arrhythmias.

Detailed description

Non-invasive mapping using the Cardio Insight system is prospectively performed routinely in heart failure patients requiring cardiac resynchronization therapy. Control patients are included, requiring chronic permanent right ventricular pacing. Specific focus include: optimization of programming parameters, pacing-induced cardiomyopathy, ventricular arrhythmias, defibrillation threshold testing and electrical shocks.

Interventions

DIAGNOSTIC_TESTNon invasive epicardial mapping

Non invasive mapping using Cardio Insight system is performed in all included patients.

Sponsors

University Hospital, Tours
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients implanted with a biventricular pacing device (CRT) device * Patients chronically implanted with a right ventricular pacing device.

Exclusion criteria

* Age \<18 years

Design outcomes

Primary

MeasureTime frameDescription
Ventricular activation mapUp to 6 monthsDifferences (qualitative and quantitative measurements) in ventricular activation patterns are identified.
Response to CRTUp to 2 yearsComposite endpoint : volumetric response, heart failure hospitalizations, and all-cause mortality.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026